Roivant Sciences (ROIV)CEO bought ~$50K

~$50K

Approx. value · 3,315 sh @ $15.07

17.3M

Holds after · shares reported

Traded

Sep 18, 2025

Filed

Sep 18, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jun 17, 2025CongressDisclosed purchase of ROIV — reported range $1,001 - $15,000
2. Jul 21, 2025InsiderCEO sold ~$1.15M of ROIV shares in the open market
3. Aug 20, 2025InsiderCEO sold ~$1.17M of ROIV shares in the open market
4. Sep 3, 2025Insider10% owner sold ~$14.9M of ROIV shares in the open market
5. Sep 4, 2025Insider10% owner sold ~$2.52M of ROIV shares in the open market
6. Sep 5, 2025Insider10% owner sold ~$5M of ROIV shares in the open market
7. Sep 18, 2025 · this disclosureInsider · First insider buy since Nov 2022CEO purchased ~$50K of ROIV shares in the open market

What came next

1. Sep 19, 2025Insider · Their largest sale since 2022CEO sold ~$10.2M of ROIV shares in the open market
2. Sep 22, 2025Insider · 1 personInsiders: 2 sales (~$6.2M)
3. Sep 23, 2025InsiderCEO sold ~$9.06M of ROIV shares in the open market
4. Oct 6, 2025InsiderCEO sold ~$2.8M of ROIV shares in the open market
5. Oct 7, 2025InsiderCEO sold ~$5.74M of ROIV shares in the open market
6. Oct 8, 2025InsiderCEO sold ~$2.25M of ROIV shares in the open market
7. Oct 9, 2025InsiderCEO sold ~$1.71M of ROIV shares in the open market
8. Oct 13, 2025InsiderCEO sold ~$337K of ROIV shares in the open market
9. Oct 15, 2025InsiderCEO sold ~$7.02M of ROIV shares in the open market
10. Oct 16, 2025InsiderCEO sold ~$5.43M of ROIV shares in the open market
11. Oct 17, 2025InsiderCEO sold ~$2.02M of ROIV shares in the open market
12. Oct 30, 2025Congress · 1 personMembers of Congress: 1 purchase, 1 sale
13. Oct 31, 2025CongressDisclosed sale of ROIV — reported range $1,001 - $15,000
14. Nov 7, 2025InsiderCEO sold ~$4.04M of ROIV shares in the open market
15. Nov 10, 2025Company filing · Form 8-K · ResultsReported its results
16. Nov 13, 2025Insider10% owner sold ~$5.98M of ROIV shares in the open market
17. Nov 14, 2025Insider10% owner sold ~$20.9M of ROIV shares in the open market
18. Nov 17, 2025Insider10% owner sold ~$11.1M of ROIV shares in the open market
19. Nov 19, 2025Insider · 3 peopleInsiders: 12 sales (~$78.9M)
20. Dec 9, 2025InsiderCEO sold ~$4.17M of ROIV shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Roivant Sciences

For Roivant Sciences, OQRO holds 18 insider filings (SEC Form 4 or Form 144) and 10 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ROIV page.

Other recent filings by Matthew Gline, CEO

• SEC Form 4 at Roivant Sciences (ROIV)Apr 21, 2026
• SEC Form 4 at Roivant Sciences (ROIV)Dec 18, 2025
• SEC Form 4 at Roivant Sciences (ROIV)Dec 18, 2025
• SEC Form 4 at Roivant Sciences (ROIV)Dec 18, 2025

The full history of Matthew Gline, CEO is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Roivant Sciences

• SEC Form 4Oct 6, 2026
• SEC Form 4Oct 6, 2026
• SEC Form 4Oct 3, 2026
• SEC Form 4Sep 18, 2026
• SEC Form 4Sep 18, 2026
• SEC Form 4Sep 18, 2026

Everything OQRO holds on this company is on its ROIV page.